Wagner M
Mod Healthc. 1990 May 28;20(21):26-8, 30, 32-3.
Despite recent scandals at generic drug companies that raised questions about quality and supply, few hospitals have shunned the off-brand products altogether. With stepped-up scrutiny of the industry by the Food and Drug Administration and purchasing groups, hospitals continue to show confidence in generics as a prescription for savings.
尽管近期仿制药公司的丑闻引发了对质量和供应的质疑，但很少有医院完全避开非专利药品。随着美国食品药品监督管理局和采购团体对该行业审查力度的加大，医院继续对仿制药作为节省开支的处方表现出信心。
